California firm takes cannabinoid research personally

by Invesbrain Tuesday, July 18, 2017
Print This Article

California firm looks to Israel for personalized cannabinoid approach

The news magazine ISRAEL21c reports a U.S. biopharma company is teaming up with an Israeli counterpart to forward the use of cannabinoids in the field of personalized medicine.

California-based CURE Pharmaceutical recently signed a memorandum of understanding with Therapix Biosciences of Tel Aviv. The “research collaboration” will be done in conjunction with the eight hospitals and medical centres of Israel’s Assuta Medical Centers.

Therapix’s lead compound THX-TS01 is currently in phase 2 clinical trials to treat Tourette’s syndrome. It hopes to begin a Phase 1 clinical trial for another compound, THX-ULD01, for the treatment of mild cognitive impairment.

Both compounds employ an “FDA-approved synthetic THC.”

Therapix is also developing new cannabinoid delivery technologies including nasal and sublingual (under the tongue) methods.

(READ MORE)

CMAJ commentary argues for two-stream cannabis system

Arguing ‘recreational cannabis and cannabinoid-based drugs (including medical cannabis) are not equivalent,’ the authors of a commentary in the Canadian Medical Association Journal say Canada should continue with a separate medical cannabis stream after legalization.

In a report by EurekAlert!, Elizabeth Cairns and Dr. Melanie Kelly of Dalhousie University’s Department of Pharmacology, write that “(without) a program that supports medical use, patients may lose access to treatments that the Federal Court of Canada has deemed appropriate, which fosters safe and appropriate use."

The Task Force on Cannabis Legalization and Regulation also recommended a two-streamed system.
According to the EurekAlert! report, “the authors suggest that a medical stream for cannabis and cannabinoids would reduce risk to patients, provide incentives for research into the therapeutic effects of cannabinoids, and provide educational resources for health care practitioners on the latest advances in cannabinoid research.”

(READ MORE)

U.S.-German-Israeli deal links cancer diagnostics with cannabinoids

MMJ Reporter writes an American cannabinoid firm with an R&D foothold in Israel is teaming up with a German “world pioneer in cancer diagnostics.”

Cannabics Pharmaceuticals Inc. recently agreed to become “the exclusive international provider unit” of SIMFO GmbH’s Circulating Tumour Cell (CTC) diagnostics to people suffering with cancer and being treated with CBDs.

SIMFO previously initiated preclinical trials into CBDs and drug development with Cannabics’ cannabinoid formulations.

Cannabics’ R&D facility is “concentrated” in Israel.

(READ MORE)

Data on CBD analogue to be presented at neuroscience meeting

Stockhouse reports Califonia-based NEMUS Bioscience is set to present research on its CBD analogue at the Annual Meeting of the Society of Neuroscience this November.

The data, compiled by NEMUS’ R&D partner the University of Mississippi “will show the superiority of the NEMUS proprietary analogue of CBD, NB2222, versus plant-derived CBD in ameliorating pain in a validated mouse (murine) model of chemotherapy-induced peripheral neuropathy using an opioid as an active comparator.”

The firm will also present data on the anti-addictive potential of NB2222.

"We have been able to demonstrate that NB2222 was able to deliver analgesia comparable to morphine, which has been implicated in the current global opioid abuse epidemic. The research team then moved to the next step using a validated animal model of addiction to opioids to assess the anti-abuse potential of NB2222 as a therapeutic. We look forward to presenting the data this fall," said Dr. Kenneth Sufka, research professor with the National Center for Natural Products Research at UM.

(READ MORE)

Upcoming Supreme Court Case to determine the fate of Vancouver’s dispensaries

There is a huge case about to go before the BC Supreme Court in September- a group of around 50 dispensaries in Vancouver are joining together in a test case to file a challenge of the city’s zoning bylaws- which are often used to deny dispensaries business licenses- in a prec...

Henry Rollins Wants You to Know: Change is Coming

Henry Rollins is a lot of things. He’s the former lead singer of one of punk rock’s most influential bands. He’s an actor who’s worked alongside the likes of Al Pacino. He’s a published author with a regular column in LA Weekly. He’s also an advocate. But Rollins doe...

Pennsylvania City Decriminalizes Marijuana Possession

Marijuana-policy reform is speeding along in Pennsylvania despite a late start. The crucial swing state, hit hard by the opiate crisis, legalized medical cannabis just two years ago. But state-funded universities are jumping feet-first into cannabis research, showing initiative ...

What Is Shatter?: The Science Behind the Golden Glass

Cannabis concentrates have been around for about as long as humans have been enjoying the benefits of cannabis, but the way they’re made and consumed has evolved dramatically in just the past few years. If there’s a single style of concentrate that epitomizes this seismic sh...

Commodity Volatility 2018-05-18 Video

I posted an additional article regarding this weeks video. This is a link specific to the video. The US Dollar is working real hard against the commodity up trend, but some of the commodities cannot be suppressed. Oil, Natural Gas, Heating Oil, Gasoline, and KOL are all soaring....

What should Mike do with his $10,000 inheritance?

Time to splurge with your inheritance cheque? (Shutterstock) Q. I just inherited $10,000. What should I do with the money? I am 65 years old and retired. I live on a very limited income which doesn’t allow me to enjoy some of the more frivolous things in life. Any good ideas...

Tech Talk for Monday May 21st 2018

Pre-opening Comments for Monday May 21st U.S. equity index futures were higher this morning. S&P 500 futures were up 15 points in pre-opening trade. Index futures responded to news that trade negotiations between China and the U.S. are progressing. Big Lots (BIG $41.64) is expe...

Florida Patients Fight for the Right to Spark Up

On Wednesday, Florida medical marijuana patients argued for the right to smoke marijuana during a court case in Tallahassee. The plaintiffs argued that they already had the right to smoke cannabis because, in the 2016 ballot measure that Florida voters approved, the “medical...

Youth Movement Protests Pot Prohibition in Ex-Soviet Georgia

Thousands of young people gathered in front of the Georgian parliament building in capital Tbilisi on May 12 — not over a contested election, the sort of thing that usually sparks demonstrations in the former Soviet republics, but to protest police drug raids on two nightclubs...

Reefer’s Closet: Medical Marijuana Apparel

Pot leaf prints are more prevalent then ever, but before medical marijuana laws began gaining traction across the United States, cannabis fashion was limited to red, gold and green Bob Marley gear and a smoky concert shirt or two. In the past, it was not only more difficult to h...